PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2006 | 6 |
| 2007 | 9 |
| 2008 | 27 |
| 2009 | 25 |
| 2010 | 47 |
| 2011 | 54 |
| 2012 | 53 |
| 2013 | 49 |
| 2014 | 26 |
| 2015 | 40 |
| 2016 | 37 |
| 2017 | 29 |
| 2018 | 35 |
| 2019 | 42 |
| 2020 | 42 |
| 2021 | 49 |
| 2022 | 9 |
| 2023 | 18 |
| 2024 | 19 |
| 2025 | 40 |
| 2026 | 14 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"J Neuroimmune Pharmacol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Fraxetin Ameliorates Cognitive Impairment in STZ-Induced Mice: Involvement of Suppressed Microglial Hyperactivation and Improved Mitochondrial Dysfunction.
- Zhao J, Bai Y, Wang C, Guo P, Wang Z, Du G, Liu A.
- J Neuroimmune Pharmacol. 2026 Oct 9;21(1):53. doi: 10.1007/s11481-026-10320-y.
- PMCID: PMC13652893
Zhao J, et al.J Neuroimmune Pharmacol. 2026.PMCID: PMC13652893 -
Palmitic Acid Amplifies Microglial Inflammatory Activation Involving C5aR1-Sensitive Inflammatory Signaling and JMJD3/H3K27me3-Related Epigenetic Changes.
- Chen L, Xu S, Liu Y, Luo X.
- J Neuroimmune Pharmacol. 2026 Aug 26;21(1):44. doi: 10.1007/s11481-026-10308-8.
- PMCID: PMC13518505
Chen L, et al.J Neuroimmune Pharmacol. 2026.PMCID: PMC13518505 -
Correction: Antioxidant‑Effective Quercetin Through Modulation of Brain Interleukin‑13 Mitigates Autistic‑Like Behaviors in the Propionic Acid‑Induced Autism Model in Rats.
- Kılıç KD, Garipoğlu G, Çakar B, Uyanıkgil Y, Erbaş O.
- J Neuroimmune Pharmacol. 2026 Aug 20;21(1):41. doi: 10.1007/s11481-026-10310-0.
- PMCID: PMC13493392
Kılıç KD, et al.J Neuroimmune Pharmacol. 2026.PMCID: PMC13493392 -
Effects of Morphine on Gp120-induced Neuroinflammation Under Immunocompetent Vs. Immunodeficient Conditions.
- Canonico D, Casale S, Look T, Cao L.
- J Neuroimmune Pharmacol. Author manuscript. 2022 Jan 21;18(1-2):24-40. doi: 10.1007/s11481-021-10040-5.
- PMCID: PMC13428667
Canonico D, et al.J Neuroimmune Pharmacol. Author manuscript. 2022.PMCID: PMC13428667 -
Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Diminish CD16+ Monocyte-Induced Astrocyte Inflammation, while THC Uniquely Inhibits Monocyte Chemotaxis Independent of HIV Status.
- Sermet S, Crawford RB, Gulick P, Kaminski NE.
- J Neuroimmune Pharmacol. 2026 Jul 4;21(1):32. doi: 10.1007/s11481-026-10300-2.
- PMCID: PMC13332895
Sermet S, et al.J Neuroimmune Pharmacol. 2026.PMCID: PMC13332895 -
Neuroimmune Correlates of HIV and Marijuana Use: Peripheral Biomarkers and Cognitive Function.
- Larson ME, Romero-Sandoval EA, Towe SL, Carrico AW, Meade CS.
- J Neuroimmune Pharmacol. 2026 Jun 23;21(1):31. doi: 10.1007/s11481-026-10299-6.
- PMCID: PMC13287204
Larson ME, et al.J Neuroimmune Pharmacol. 2026.PMCID: PMC13287204 -
Stimulant Use, HIV, and Plasma Metabolites Among Men.
- Cherenack EM, Larson ME, Murray K, Mayer ZJ, Guerrero C, Broedlow CA, Klatt NR, Carrico AW.
- J Neuroimmune Pharmacol. Author manuscript. 2025 Jun 19;20(1):68. doi: 10.1007/s11481-025-10223-4.
- PMCID: PMC12239224
Cherenack EM, et al.J Neuroimmune Pharmacol. Author manuscript. 2025.PMCID: PMC12239224 -
Neuroimmunomodulation of AMPA Receptors Through Combination of Medium-Chain Triglycerides and Perampanel to Treat Status Epilepticus in Anti-NMDA Receptor Encephalitis.
- Stadler LM, Schappe L, Lochner P, Bonifer L, Fousse M, Meuth SG, Groppa S, Winter Y.
- J Neuroimmune Pharmacol. 2026 May 19;21(1):26. doi: 10.1007/s11481-026-10295-w.
- PMCID: PMC13186854
Stadler LM, et al.J Neuroimmune Pharmacol. 2026.PMCID: PMC13186854 -
CA Inhibitor 1 Treatment Does Not Affect Estrous Cyclicity in Mice.
- Giacometti LL, Dalere DM, Lwamba B, Goldberg SL, Feliciano K, Barker JM.
- J Neuroimmune Pharmacol. 2026 May 9;21(1):24. doi: 10.1007/s11481-026-10293-y.
- PMCID: PMC13157429
Giacometti LL, et al.J Neuroimmune Pharmacol. 2026.PMCID: PMC13157429 -
Virus-like peptide vaccines against Abeta N-terminal or C-terminal domains reduce amyloid deposition in APP transgenic mice without addition of adjuvant.
- Li QY, Gordon MN, Chackerian B, Alamed J, Ugen KE, Morgan D.
- J Neuroimmune Pharmacol. Author manuscript. 2010 Mar;5(1):133-42. doi: 10.1007/s11481-009-9183-1.
- PMCID: PMC13019653
Li QY, et al.J Neuroimmune Pharmacol. Author manuscript. 2010.PMCID: PMC13019653